Nukkleus Inc. Announces Filing of Corporate-Sponsored SPAC Registration Statement
Nukkleus (NASDAQ:NUKK) announced it is the majority owner of the sponsor of a newly formed SPAC, SC II Acquisition Corp. On October 16, 2025 SC II filed a preliminary Form S-1 to pursue an IPO of units to raise $150 million at an expected unit price of $10.00 each, with an underwriter option for an additional $22.5 million. Each unit is expected to consist of one Class A share and a right to 1/5 of a Class A share upon a business combination. SC II intends to list units on Nasdaq Global Market as SCIIU. Menachem Shalom is expected to serve as CEO of SC II. The registration statement is preliminary and there is no assurance the IPO or any business combination will occur.
Nukkleus (NASDAQ:NUKK) ha annunciato di essere l'attuale maggior azionista del sponsor di una SPAC di nuova formazione, SC II Acquisition Corp. Il 16 ottobre 2025 SC II ha depositato una Form S-1 preliminare per inseguire un IPO di unità per raccogliere 150 milioni di dollari a un prezzo unitario previsto di 10,00 dollari ciascuna, con un'opzione di collocamento per ulteriori 22,5 milioni di dollari. Ogni unità dovrebbe constare di una azione di Classe A e di un diritto a 1/5 di un'azione di Classe A al momento di una business combination. SC II intende elencare le unità su Nasdaq Global Market come SCIIU. Si prevede che Menachem Shalom fungerà da CEO di SC II. La dichiarazione di registrazione è preliminare e non vi è alcuna garanzia che l'IPO o qualsiasi business combination avvenga.
Nukkleus (NASDAQ:NUKK) anunció que es el propietario mayoritario del sponsor de una SPAC recién formada, SC II Acquisition Corp. El 16 de octubre de 2025, SC II presentó un Formulario S-1 preliminar para buscar una OPV de unidades para recaudar 150 millones de dólares a un precio unitario esperado de 10,00 dólares cada una, con una opción de suscripción para otros 22,5 millones de dólares. Cada unidad se espera que consista en una acción de Clase A y un derecho a 1/5 de una acción de Clase A tras una combinación de negocios. SC II tiene la intención de cotizar unidades en Nasdaq Global Market como SCIIU. Se espera que Menachem Shalom se desempeñe como CEO de SC II. La declaración de registro es preliminar y no hay garantía de que la OPV o cualquier combinación de negocios ocurra.
Nukkleus (NASDAQ:NUKK) 는 신설 SPAC의 스폰서의 다수 주주임을 발표했습니다, SC II Acquisition Corp. 2025년 10월 16일 SC II는 IPO를 추진하기 위해 예비 Form S-1을 제출했고, 유닛 공모를 통해 1억 5천만 달러를 모으고 각 유닛의 예상 가격은 10.00달러이며, 추가로 2250만 달러의 언더라이터 옵션이 있습니다. 각 유닛은 Class A 주식 1주와 비즈니스 결합 시 Class A 주식의 1/5에 해당하는 권리를 포함하는 것으로 예상됩니다. SC II는 Nasdaq Global Market에 SCIIU로 유닛 상장을 목표로 합니다. Menachem Shalom은 SC II의 CEO로 재직할 예정입니다. 등록 서류는 예비적이며 IPO나 어떤 비즈니스 결합도 일어날 것이라는 보장은 없습니다.
Nukkleus (NASDAQ:NUKK) a annoncé être le propriétaire majoritaire du sponsor d'une SPAC nouvellement formée, SC II Acquisition Corp. Le 16 octobre 2025, SC II a déposé une pré-Form S-1 afin de poursuivre une IPO de unités pour lever 150 millions de dollars à un prix unitaire prévu de 10,00 dollars chacun, avec une option de souscription pour 22,5 millions de dollars supplémentaires. Chaque unité devrait comprendre une action de Classe A et un droit à 1/5 d'une action de Classe A lors d'une combinaison d'affaires. SC II envisage de répertorier les unités sur le Nasdaq Global Market sous le symbole SCIIU. Menachem Shalom devrait occuper le poste de PDG de SC II. Le formulaire d'enregistrement est préliminaire et il n'y a aucune assurance que l'IPO ou toute combinaison d'affaires ait lieu.
Nukkleus (NASDAQ:NUKK) gab bekannt, dass es der Mehrheitsinhaber des Sponsors einer neu gegründeten SPAC ist, SC II Acquisition Corp. Am 16. Oktober 2025 legte SC II einen vorläufigen Form S-1 ein, um eine IPO von Einheiten zu verfolgen, um 150 Millionen US-Dollar zu generieren, zu einem erwarteten Einheitspreis von 10,00 US-Dollar je Einheit, mit einer Underwriter-Option für zusätzliche 22,5 Millionen US-Dollar. Jede Einheit soll aus einer Class A-Aktie und einem Recht auf 1/5 einer Class A-Aktie bei einer Geschäftsverbindung bestehen. SC II beabsichtigt, Einheiten an der Nasdaq Global Market unter dem Tickersymbol SCIIU zu listen. Menachem Shalom wird voraussichtlich als CEO von SC II fungieren. Die Registrierungsunterlage ist vorläufig, und es besteht keine Gewähr, dass der IPO oder irgendeine Geschäftsverbindung erfolgen wird.
Nukkleus (بورصة ناسداك:NUKK) أعلن أنه المالك الأكبر لرعاية SPAC التي تم تشكيلها حديثاً، SC II Acquisition Corp. في 16 أكتوبر 2025 قدمت SC II نموذج S-1 أولي للسعي لإدراج أولي للوحدات لجمع مبلغ 150 مليون دولار بسعر وحدات متوقع قدره 10.00 دولار لكل وحدة، مع خيار مكتتب إضافي بقيمة 22.5 مليون دولار. من المتوقع أن تتكون كل وحدة من سهم من الفئة A وحق في 1/5 سهم من الفئة A عند الدمج التجاري. تنوي SC II إدراج الوحدات في Nasdaq Global Market ك SCIIU. من المتوقع أن يشغل مناحم شلوم منصب الرئيس التنفيذي لـ SC II. بيان التسجيل ابتدائي ولا يوجد ضمان بأن تتم عملية الطرح العام الأولي أو أي دمج تجاري.
Nukkleus（纳斯达克股票代码NUKK）宣布它是新设立的 SPAC 的赞助方的多数股东，SC II Acquisition Corp. 于2025年10月16日提交了初步 Form S-1，拟进行单位公开发行以募集1.5亿美元，单位价格预计为每单位< b>10.00 美元，承销商另有< b>2,250 万美元的认购权。每单位预计由1股A类股票及在完成交易时获得1/5股A类股票的权利组成。SC II 打算在纳斯达克全球市场上市交易单位，股票代码为< b>SCIIU。 Menachem Shalom 预计将出任 SC II 的首席执行官。注册声明为初步文件，不能保证 IPO 或任何商业合并一定会发生。
- SPAC seeks to raise $150 million in proposed IPO
- Underwriters may purchase up to $22.5 million additional units
- SCIIU planned listing on Nasdaq Global Market
- Menachem Shalom expected to serve as SC II CEO
- Registration statement is preliminary; IPO not effective as of Oct 16, 2025
- No assurance the Form S-1 filing will result in an IPO or business combination
- Final IPO terms and offering completion are not guaranteed
Insights
Nukkleus sponsors a new SPAC (SC II) filing for a proposed IPO to raise
Nukkleus is the majority owner of the sponsor for SC II Acquisition Corp. and SCII filed a Form S-1 on
The near-term outcomes that determine materiality are explicit: whether the registration statement becomes effective and the final IPO terms. The release notes there is no assurance the filing will lead to a transaction or specific IPO terms, so regulatory clearance and definitive offering terms remain the gating items. Watch for the S-1 being declared effective, the final size and exercise of the underwriter option, and any disclosed sponsor capital or PIPE commitments; these items will clarify funding and sponsor alignment and should appear in subsequent filings or the prospectus.
NEW YORK, Oct. 17, 2025 (GLOBE NEWSWIRE) -- Nukkleus, Inc. (NASDAQ:NUKK) (“Nukkleus” or the “Company”) announced that it is the majority owner of the sponsor of a newly formed special purpose acquisition company (“SPAC”) named SC II Acquisition Corp. (“SC II”). On October 16, 2025, SCII filed a registration statement on Form S-1 with the Securities and Exchange Commission (“SEC”) in connection with a proposed initial public offering (“IPO”) of its units.
SCII intends to raise
Menachem Shalom, the Chief Executive Officer of Nukkleus, is expected to serve as the Chief Executive Officer of SC II.
D. Boral Capital LLC is acting as the book-running manager for the proposed IPO. When available, copies of the preliminary prospectus relating to the offering may be obtained from D. Boral Capital LLC: Attn: 590 Madison Avenue 39th Floor, New York, NY 10022, or by email at dbccapitalmarkets@dboralcapital.com, or by telephone at (212) 970-5150, or from the SEC’s website at www.sec.gov.
A registration statement, including a prospectus, which is preliminary and subject to completion, relating to the proposed IPO has been filed with the SEC but has not yet become effective. These securities may not be sold, nor may offers to buy be accepted, prior to the time the registration statement becomes effective. This press release shall not constitute an offer to sell or the solicitation of an offer to buy these securities, nor shall there be any sales of securities in any state or jurisdiction in which such offer, solicitation or sale would be unlawful prior to registration or qualification under the securities laws of such state or jurisdiction.
There can be no assurance the public filing of a registration statement on Form S-1 will result in any transaction or other action by SCII and there is no assurance of the final terms of such IPO. Neither Nukkleus nor SCII intends to comment on or provide updates regarding these matters unless and until it determines that further disclosure is appropriate or required based on the then-current facts and circumstances.
Forward Looking Statements
Certain statements in this press release constitute “forward-looking statements” within the meaning of the Private Securities Litigation Reform Act of 1995. Such statements include, but are not limited to, statements regarding the anticipated size, timing, structure, and success of the proposed IPO of SC II, the expected composition of its sponsor and management team, and the prospects of completing a future business combination. Forward-looking statements are based on current expectations and assumptions that are subject to risks and uncertainties that could cause actual results to differ materially. Readers are cautioned not to place undue reliance on these forward-looking statements. Except as required by law, the Company and SCII undertakes no obligation to update or revise any forward-looking statements.
For more information, please contact:
Investor Relations (US)
Lena Cati
Tel: +1 212 836-9611
lcati@theequitygroup.com
Val Ferraro
Tel: +1 212 836-9612
vferraro@theequitygroup.com
FAQ
What did Nukkleus (NUKK) announce on October 17, 2025 about a SPAC?
How much does SC II intend to raise in the proposed IPO (SCIIU)?
Who is expected to lead SC II and what is his role at Nukkleus?
What does each SC II unit consist of in the proposed offering?
Where can investors obtain the SC II preliminary prospectus for the S-1 filing?
Does the Form S-1 filing guarantee the SC II IPO will occur?
